Approval · Notice of Compliance 2863 · 1998
ETOPOSIDE: Notice of Compliance 2863
Issued May 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2863
- Date
- May 4, 1998
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Antineoplastic agent
- Canadian reference product
- VEPESID (Bristol-Myers Squibb S.R.L.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETOPOSIDE | 02237873 | Cancelled Pre Market |
Medicinal ingredients
- ETOPOSIDE 20 MG per ML